211 related articles for article (PubMed ID: 19123475)
1. Salvianolic acid B inhibits growth of head and neck squamous cell carcinoma in vitro and in vivo via cyclooxygenase-2 and apoptotic pathways.
Hao Y; Xie T; Korotcov A; Zhou Y; Pang X; Shan L; Ji H; Sridhar R; Wang P; Califano J; Gu X
Int J Cancer; 2009 May; 124(9):2200-9. PubMed ID: 19123475
[TBL] [Abstract][Full Text] [Related]
2. Combination effects of salvianolic acid B with low-dose celecoxib on inhibition of head and neck squamous cell carcinoma growth in vitro and in vivo.
Zhao Y; Hao Y; Ji H; Fang Y; Guo Y; Sha W; Zhou Y; Pang X; Southerland WM; Califano JA; Gu X
Cancer Prev Res (Phila); 2010 Jun; 3(6):787-96. PubMed ID: 20501859
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cancer cell proliferation and prostaglandin E2 synthesis by Scutellaria baicalensis.
Zhang DY; Wu J; Ye F; Xue L; Jiang S; Yi J; Zhang W; Wei H; Sung M; Wang W; Li X
Cancer Res; 2003 Jul; 63(14):4037-43. PubMed ID: 12874003
[TBL] [Abstract][Full Text] [Related]
4. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
Zweifel BS; Davis TW; Ornberg RL; Masferrer JL
Cancer Res; 2002 Nov; 62(22):6706-11. PubMed ID: 12438270
[TBL] [Abstract][Full Text] [Related]
5. Modulation of growth and angiogenic potential of oral squamous carcinoma cells in vitro using salvianolic acid B.
Yang Y; Ge PJ; Jiang L; Li FL; Zhu QY
BMC Complement Altern Med; 2011 Jul; 11():54. PubMed ID: 21726465
[TBL] [Abstract][Full Text] [Related]
6. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
Xie H; Gao L; Chai N; Song J; Wang J; Song Z; Chen C; Pan Y; Zhao L; Sun S; Wu K; Feitelson MA; Liu J; Fan D
Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760
[TBL] [Abstract][Full Text] [Related]
7. The cancer pain related factors affected by celecoxib together with cetuximab in head and neck squamous cell carcinoma.
Yang Y; Yan J; Huang Y; Xu H; Zhang Y; Hu R; Jiang J; Chen Z; Jiang H
Biomed Pharmacother; 2015 Mar; 70():181-9. PubMed ID: 25776499
[TBL] [Abstract][Full Text] [Related]
8. Vitamin E succinate induces ceramide-mediated apoptosis in head and neck squamous cell carcinoma in vitro and in vivo.
Gu X; Song X; Dong Y; Cai H; Walters E; Zhang R; Pang X; Xie T; Guo Y; Sridhar R; Califano JA
Clin Cancer Res; 2008 Mar; 14(6):1840-8. PubMed ID: 18347187
[TBL] [Abstract][Full Text] [Related]
9. Apigenin induces apoptosis via tumor necrosis factor receptor- and Bcl-2-mediated pathway and enhances susceptibility of head and neck squamous cell carcinoma to 5-fluorouracil and cisplatin.
Chan LP; Chou TH; Ding HY; Chen PR; Chiang FY; Kuo PL; Liang CH
Biochim Biophys Acta; 2012 Jul; 1820(7):1081-91. PubMed ID: 22554915
[TBL] [Abstract][Full Text] [Related]
10. Salvianolic acid B exerts vasoprotective effects through the modulation of heme oxygenase-1 and arginase activities.
Joe Y; Zheng M; Kim HJ; Kim S; Uddin MJ; Park C; Ryu DG; Kang SS; Ryoo S; Ryter SW; Chang KC; Chung HT
J Pharmacol Exp Ther; 2012 Jun; 341(3):850-8. PubMed ID: 22442118
[TBL] [Abstract][Full Text] [Related]
11. Guggulsterone (GS) inhibits smokeless tobacco and nicotine-induced NF-κB and STAT3 pathways in head and neck cancer cells.
Macha MA; Matta A; Chauhan SS; Siu KW; Ralhan R
Carcinogenesis; 2011 Mar; 32(3):368-80. PubMed ID: 21177768
[TBL] [Abstract][Full Text] [Related]
12. Effects of celecoxib treatment over the AKT pathway in head and neck squamous cell carcinoma.
Abrahão AC; Giudice FS; Sperandio FF; Pinto Junior Ddos S
J Oral Pathol Med; 2013 Nov; 42(10):793-8. PubMed ID: 23679684
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma.
St John MA
Laryngoscope; 2015 Mar; 125 Suppl 3():S1-11. PubMed ID: 25646683
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E(2) pathway in head and neck squamous cell carcinoma.
Camacho M; León X; Fernández-Figueras MT; Quer M; Vila L
Head Neck; 2008 Sep; 30(9):1175-81. PubMed ID: 18642283
[TBL] [Abstract][Full Text] [Related]
15. Salvianolic acid B, a novel autophagy inducer, exerts antitumor activity as a single agent in colorectal cancer cells.
Jing Z; Fei W; Zhou J; Zhang L; Chen L; Zhang X; Liang X; Xie J; Fang Y; Sui X; Han W; Pan H
Oncotarget; 2016 Sep; 7(38):61509-61519. PubMed ID: 27557491
[TBL] [Abstract][Full Text] [Related]
16. Salvianolic acid B attenuates cyclooxygenase-2 expression in vitro in LPS-treated human aortic smooth muscle cells and in vivo in the apolipoprotein-E-deficient mouse aorta.
Chen YL; Hu CS; Lin FY; Chen YH; Sheu LM; Ku HH; Shiao MS; Chen JW; Lin SJ
J Cell Biochem; 2006 Jun; 98(3):618-31. PubMed ID: 16440326
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
Hashitani S; Urade M; Nishimura N; Maeda T; Takaoka K; Noguchi K; Sakurai K
Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902
[TBL] [Abstract][Full Text] [Related]
18. Targeting mTOR by CZ415 Inhibits Head and Neck Squamous Cell Carcinoma Cells.
Xie J; Li Q; Ding X; Gao Y
Cell Physiol Biochem; 2018; 46(2):676-686. PubMed ID: 29621758
[TBL] [Abstract][Full Text] [Related]
19. Salvianolic Acid B, a potential chemopreventive agent, for head and neck squamous cell cancer.
Zhao Y; Guo Y; Gu X
J Oncol; 2011; 2011():534548. PubMed ID: 21209716
[TBL] [Abstract][Full Text] [Related]
20. A role for COX2-derived PGE2 and PGE2-receptor subtypes in head and neck squamous carcinoma cell proliferation.
Abrahao AC; Castilho RM; Squarize CH; Molinolo AA; dos Santos-Pinto D; Gutkind JS
Oral Oncol; 2010 Dec; 46(12):880-7. PubMed ID: 20951077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
